These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23408996)

  • 21. TPP1 Delivery to Lysosomes with Extracellular Vesicles and their Enhanced Brain Distribution in the Animal Model of Batten Disease.
    Haney MJ; Klyachko NL; Harrison EB; Zhao Y; Kabanov AV; Batrakova EV
    Adv Healthc Mater; 2019 Jun; 8(11):e1801271. PubMed ID: 30997751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis.
    Lin L; Lobel P
    Biochem J; 2001 Jul; 357(Pt 1):49-55. PubMed ID: 11415435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human pathology in NCL.
    Anderson GW; Goebel HH; Simonati A
    Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemistry of neuronal ceroid lipofuscinoses.
    Junaid MA; Pullarkat RK
    Adv Genet; 2001; 45():93-106. PubMed ID: 11332778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tripeptidyl-peptidase I in neuronal ceroid lipofuscinoses and other lysosomal storage disorders.
    Wisniewski KE; Kida E; Walus M; Wujek P; Kaczmarski W; Golabek AA
    Eur J Paediatr Neurol; 2001; 5 Suppl A():73-9. PubMed ID: 11589013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.
    Chandrachud U; Walker MW; Simas AM; Heetveld S; Petcherski A; Klein M; Oh H; Wolf P; Zhao WN; Norton S; Haggarty SJ; Lloyd-Evans E; Cotman SL
    J Biol Chem; 2015 Jun; 290(23):14361-80. PubMed ID: 25878248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial genetic suppression of a loss-of-function mutant of the neuronal ceroid lipofuscinosis-associated protease TPP1 in Dictyostelium discoideum.
    Phillips JE; Gomer RH
    Dis Model Mech; 2015 Feb; 8(2):147-56. PubMed ID: 25540127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal ceroid lipofuscinoses: research update.
    Wisniewski KE; Kida E; Connell F; Zhong N
    Neurol Sci; 2000; 21(3 Suppl):S49-56. PubMed ID: 11073228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human INCL fibroblasts display abnormal mitochondrial and lysosomal networks and heightened susceptibility to ROS-induced cell death.
    Balouch B; Nagorsky H; Pham T; LaGraff JT; Chu-LaGraff Q
    PLoS One; 2021; 16(2):e0239689. PubMed ID: 33561134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses.
    Weleber RG
    Eye (Lond); 1998; 12 ( Pt 3b)():580-90. PubMed ID: 9775220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neuronal ceroid-lipofuscinoses. Recent advances.
    Goebel HH; Sharp JD
    Brain Pathol; 1998 Jan; 8(1):151-62. PubMed ID: 9458173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
    Mole SE; Mitchison HM; Munroe PB
    Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain lysosomal hydrolases in neuronal ceroid-lipofuscinoses.
    Prasad VV; Pullarkat RK
    Mol Chem Neuropathol; 1996; 29(2-3):169-79. PubMed ID: 8971694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis.
    Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N
    Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neuronal ceroid-lipofuscinoses.
    Bennett MJ; Rakheja D
    Dev Disabil Res Rev; 2013; 17(3):254-9. PubMed ID: 23798013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CLN-encoded proteins do not interact with each other.
    Zhong NA; Moroziewicz DN; Ju W; Wisniewski KE; Jurkiewicz A; Brown WT
    Neurogenetics; 2000 Sep; 3(1):41-4. PubMed ID: 11085596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysosomal membrane permeability stimulates protein aggregate formation in neurons of a lysosomal disease.
    Micsenyi MC; Sikora J; Stephney G; Dobrenis K; Walkley SU
    J Neurosci; 2013 Jun; 33(26):10815-27. PubMed ID: 23804102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tripeptidyl-peptidase I deficiency in classical late-infantile neuronal ceroid lipofuscinosis brain tissue. Evidence for defective peptidase rather than proteinase activity.
    Warburton MJ; Bernardini F
    J Inherit Metab Dis; 2000 Mar; 23(2):145-54. PubMed ID: 10801056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal ceroid lipofuscinoses: pathological features of bioptic specimens from 28 patients.
    Simonati A; Rizzuto N
    Neurol Sci; 2000; 21(3 Suppl):S63-70. PubMed ID: 11073230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anomalies of mitochondrial ATP synthase regulation in four different types of neuronal ceroid lipofuscinosis.
    Das AM; Jolly RD; Kohlschütter A
    Mol Genet Metab; 1999 Apr; 66(4):349-55. PubMed ID: 10191128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.